Active ingredientTipelukastCat. No. P-T130-001CAS 125961-82-2Family · Pharmaceutical analytical standards
Tipelukast
An experimental oral molecule that blocks leukotriene receptors, mediators of inflammation: studied first in asthma and then in idiopathic pulmonary fibrosis, for which it received orphan drug designation in the United States in 2014. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It does not hit just one target: besides leukotriene receptors it also acts on phosphodiesterases and on 5-lipoxygenase, the enzyme that produces leukotrienes in the first place.
Go to the active ingredient →Active ingredientTipelukastCat. No. P-T130-001CAS 125961-82-2
Isotopically labelledHydroxy Tipelukast-d6Cat. No. P-T130-002
Isotopically labelledHydroxy Tipelukast-d6 Sodium SaltCat. No. P-T130-003
Isotopically labelledTipelukast-d6Cat. No. P-T130-004
ImpurityHydroxy TipelukastCat. No. P-T130-005CAS 1027597-04-1
ImpurityHydroxy Tipelukast Sodium SaltCat. No. P-T130-006No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.